Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Nov 23;14:1304466. doi: 10.3389/fimmu.2023.1304466

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 Ding, Zhao, Cai, Zhou, Chen, Bai, Liu, Liu and Zhou

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Prediction of immunotherapy response (A) Prognoses differences between risk subgroups in the IMvigor210 cohort; Differences between immunotherapy responses; Distribution of immunotherapy response. (B) Prognostic differences between risk subgroups in the GSE78220 cohort; Differences between immunotherapy responses; Distribution of immunotherapy response. (C) Prognostic differences between risk subgroups based on early-stage (stage I-II) and late-stage (stage III-IV) patients in the two cohorts. *P < 0.05, ****P < 0.0001.